Antitrust Antitrust

Japan drug wholesalers Alfresa, Toho and Suzuken to be fined total of $3.6 million for price cartel

By Toko Sekiguchi
  • 07 Feb 2022 00:56
  • 07 Feb 2022 01:35
Japan’s top pharmaceutical wholesalers Alfresa, Toho Pharmaceutical and Suzuken will be fined 416 million yen ($3.6 million) for rigging bids of prescription drugs sold in 57 hospitals nation-wide through a quasi-public healthcare management operator, MLex has learned.
Alfresa, Toho and Suzuken, will be sanctioned 170 million yen, 160 million yen,

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Toko Sekiguchi

Senior Correspondent, Tokyo

Toko is a senior correspondent in Tokyo covering antitrust, anti-bribery & corruption, financial services and regulatory issues in Japan. Before joining MLex, she has worked as a journalist for The Wall Street Journal, Dow Jones News, Bloomberg News and Time Magazine.

Discover MLex

Stay on top of global regulatory developments

Latest News